Traded May 12 · filed 1 day later
Derivative exercise or conversion — not an open-market buy.
Loading…
Traded Apr 14, 2026 · Filed Apr 16, 2026
The CEO of The Vita Coco sold $1.25M of The Vita Coco shares. The filing says it was made under a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$1,250,000
Shares × reported transaction price
55 days after results of Feb 18, 2026, 15 days before results of Apr 29, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +4.3% | +0.5% | +3.7% |
| 30 days | +64.0% | +4.0% | +60.0% |
| 90 days | +51.6% | +5.7% | +45.9% |
Past results only. Not a forecast.
Traded May 12 · filed 1 day later
Derivative exercise or conversion — not an open-market buy.
Jonathan Burth (Chief Operating Officer) sold ~$2.25M of The Vita Coco Company
Scheduled in advanceTraded May 12 · filed 1 day later
Derivative exercise or conversion — not an open-market buy.